Source: Frontiers in Immunology. Unidades: ICB, FM
Subjects: IMUNOLOGIA, MOLÉCULAS DE ADESÃO CELULAR, CÉLULAS DENDRÍTICAS, INFECÇÕES POR HIV, CITOCINAS, ADJUVANTES IMUNOLÓGICOS, MONÓCITOS, INIBIDORES QUÍMICOS
ABNT
REIS, Edione Cristina dos et al. Flagellin/NLRC4 pathway rescues NLRP3-inflammasome defect in dendritic cells from HIV-infected patients: perspective for new adjuvant in immunocompromised individuals. Frontiers in Immunology, v. 10, p. 13 , 2019Tradução . . Disponível em: https://doi.org/10.3389/fimmu.2019.01291. Acesso em: 16 nov. 2024.APA
Reis, E. C. dos, Leal, V. N. C., Silva, J. S. L. da, Fernandes, F. P., Lima, D. S. de, Bargieri, B. C. de A., & Pontillo, A. (2019). Flagellin/NLRC4 pathway rescues NLRP3-inflammasome defect in dendritic cells from HIV-infected patients: perspective for new adjuvant in immunocompromised individuals. Frontiers in Immunology, 10, 13 . doi:10.3389/fimmu.2019.01291NLM
Reis EC dos, Leal VNC, Silva JSL da, Fernandes FP, Lima DS de, Bargieri BC de A, Pontillo A. Flagellin/NLRC4 pathway rescues NLRP3-inflammasome defect in dendritic cells from HIV-infected patients: perspective for new adjuvant in immunocompromised individuals [Internet]. Frontiers in Immunology. 2019 ; 10 13 .[citado 2024 nov. 16 ] Available from: https://doi.org/10.3389/fimmu.2019.01291Vancouver
Reis EC dos, Leal VNC, Silva JSL da, Fernandes FP, Lima DS de, Bargieri BC de A, Pontillo A. Flagellin/NLRC4 pathway rescues NLRP3-inflammasome defect in dendritic cells from HIV-infected patients: perspective for new adjuvant in immunocompromised individuals [Internet]. Frontiers in Immunology. 2019 ; 10 13 .[citado 2024 nov. 16 ] Available from: https://doi.org/10.3389/fimmu.2019.01291